Nothing Special   »   [go: up one dir, main page]

ES2075074T3 - Acidos 3-fenil-5,6-dihidrobenzo(c)-acridin-7-carboxilicos y compuestos relacionados como agentes quimioterapeuticos para el cancer. - Google Patents

Acidos 3-fenil-5,6-dihidrobenzo(c)-acridin-7-carboxilicos y compuestos relacionados como agentes quimioterapeuticos para el cancer.

Info

Publication number
ES2075074T3
ES2075074T3 ES90101253T ES90101253T ES2075074T3 ES 2075074 T3 ES2075074 T3 ES 2075074T3 ES 90101253 T ES90101253 T ES 90101253T ES 90101253 T ES90101253 T ES 90101253T ES 2075074 T3 ES2075074 T3 ES 2075074T3
Authority
ES
Spain
Prior art keywords
carboxylics
acridin
dihydrobenzo
cancer
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90101253T
Other languages
English (en)
Inventor
Carl Henry Behrens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
DuPont Merck Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DuPont Merck Pharmaceutical Co filed Critical DuPont Merck Pharmaceutical Co
Application granted granted Critical
Publication of ES2075074T3 publication Critical patent/ES2075074T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/02—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with only hydrogen, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

DERIVADOS DE ACIDO CARBOXILICO DE DIHIDROBENZ(C)ACRIDINA QUE RESULTAN DE GRAN UTILIDAD EN EL TRATAMIENTO DE TUMORES DE MAMIFEROS. ESTOS DERIVADOS PROCEDEN DE LA FORMULA: O UNA SAL FARMACEUTICAMENTE ACEPTABLE, EN DONDE R1, R2, R3, R4 Y R5 SON TAL Y COMO SE DEFINEN EN LA ESPECIFICACION. ASIMISMO, SE PROPORCIONAN COMPOSICIONES FARMACEUTICAS DE DICHOS COMPUESTOS. TAMBIEN SE REVELAN LOS PROCESOS DE PREPARACION DE ESTOS COMPUESTOS.
ES90101253T 1989-01-25 1990-01-23 Acidos 3-fenil-5,6-dihidrobenzo(c)-acridin-7-carboxilicos y compuestos relacionados como agentes quimioterapeuticos para el cancer. Expired - Lifetime ES2075074T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/301,379 US4918077A (en) 1989-01-25 1989-01-25 3-phenyl-5,6-dihydrobenz(c)acridine-7-carboxylic acids and related compounds as cancer chemotherapeutic agents

Publications (1)

Publication Number Publication Date
ES2075074T3 true ES2075074T3 (es) 1995-10-01

Family

ID=23163099

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90101253T Expired - Lifetime ES2075074T3 (es) 1989-01-25 1990-01-23 Acidos 3-fenil-5,6-dihidrobenzo(c)-acridin-7-carboxilicos y compuestos relacionados como agentes quimioterapeuticos para el cancer.

Country Status (21)

Country Link
US (2) US4918077A (es)
EP (1) EP0380038B1 (es)
JP (1) JPH0662572B2 (es)
KR (1) KR910006985B1 (es)
AT (1) ATE124399T1 (es)
AU (1) AU623481B2 (es)
CA (1) CA2007529A1 (es)
DE (1) DE69020368T2 (es)
DK (1) DK0380038T3 (es)
ES (1) ES2075074T3 (es)
FI (1) FI95374C (es)
GR (1) GR3016979T3 (es)
HU (1) HU205743B (es)
IE (1) IE68761B1 (es)
IL (1) IL93161A0 (es)
MY (1) MY104829A (es)
NO (1) NO176961C (es)
NZ (1) NZ232207A (es)
PT (1) PT92952B (es)
RU (1) RU1779247C (es)
ZA (1) ZA90545B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135934A (en) * 1990-07-06 1992-08-04 Du Pont Merck Pharmaceutical Company 3-phenyl-5,6-dihydrobenz(c) acridine-7-carboxylic acids and related compounds as immunosuppressive agents
DK0601191T3 (da) * 1992-04-24 1999-04-26 Kyowa Hakko Kogyo Kk Hidtil ukendt tetracyklisk forbindelse
US5807549A (en) * 1993-05-21 1998-09-15 Research Corporation Technologies, Inc. Lymphocyte chemoattractant factor and uses thereof
US5428040A (en) * 1993-08-31 1995-06-27 The Du Pont Merck Pharmaceutical Company Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents
DE69430752T2 (de) * 1993-09-28 2002-10-17 Kyowa Hakko Kogyo Co., Ltd. Tetracyclische verbindungen
GB9400585D0 (en) * 1994-01-13 1994-03-09 Guest John D Improvements in or relating to tube couplings
JP3141148B2 (ja) * 1995-08-08 2001-03-05 大鵬薬品工業株式会社 縮合インダン誘導体及びその塩
AU2896097A (en) * 1996-05-10 1997-12-05 Novartis Ag Use of brequinar and derivatives in chronic rejection of allografts and xenotransplantation
US7847125B2 (en) * 2007-11-16 2010-12-07 Chemtura Corporation Acridan derivatives as antioxidants
CN102351870B (zh) * 2011-08-25 2014-03-12 中山大学 一种苯并吖啶衍生物的制备方法及其作为抗癌药物的用途
CA2930429A1 (en) 2013-11-22 2015-05-28 Genzyme Corporation Novel methods for treating neurodegenerative diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE502610A (es) * 1950-04-18
US4680299A (en) * 1984-04-30 1987-07-14 E.I. Du Pont De Nemours And Company 2-phenyl-4-quinolinecarboxylic acids and pharmaceutical compositions thereof
DE3483704D1 (de) * 1983-07-22 1991-01-17 Du Pont Phenylchinolinsaeure und derivate als antitumormittel.
US4847381A (en) * 1987-08-31 1989-07-11 American Cyanamid Company 2-Phenyl-4-quinoline carboxylic acids

Also Published As

Publication number Publication date
US5002954A (en) 1991-03-26
NO900342L (no) 1990-07-26
NO176961C (no) 1995-06-28
JPH0662572B2 (ja) 1994-08-17
KR910006985B1 (ko) 1991-09-14
NO176961B (no) 1995-03-20
US4918077A (en) 1990-04-17
AU4874590A (en) 1990-08-02
EP0380038B1 (en) 1995-06-28
DE69020368T2 (de) 1995-11-09
FI95374C (fi) 1996-01-25
KR900011735A (ko) 1990-08-02
ZA90545B (en) 1991-09-25
IE900267L (en) 1990-07-25
ATE124399T1 (de) 1995-07-15
FI900365A0 (fi) 1990-01-24
HU205743B (en) 1992-06-29
NO900342D0 (no) 1990-01-24
EP0380038A2 (en) 1990-08-01
AU623481B2 (en) 1992-05-14
PT92952B (pt) 1995-12-29
NZ232207A (en) 1991-08-27
JPH02233661A (ja) 1990-09-17
EP0380038A3 (en) 1991-11-13
MY104829A (en) 1994-06-30
DK0380038T3 (da) 1995-08-28
FI95374B (fi) 1995-10-13
IL93161A0 (en) 1990-11-05
RU1779247C (ru) 1992-11-30
DE69020368D1 (de) 1995-08-03
PT92952A (pt) 1990-07-31
GR3016979T3 (en) 1995-11-30
HU900255D0 (en) 1990-03-28
HUT53880A (en) 1990-12-28
CA2007529A1 (en) 1990-07-25
IE68761B1 (en) 1996-07-10

Similar Documents

Publication Publication Date Title
NO900306D0 (no) Fremgangsmaate for fremstilling av nye pyrazolopyridin-forbindelser.
FI103047B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten bentso£de|pyrano£3', 4':6,7|indolitsino£1,2-b|kinoliinijohdannaisten valmistamiseksi
HUT48589A (en) Process for production of new derivatives of substituated n-/1-hydroxi-4-piperidinil/-benzamid
ES2075074T3 (es) Acidos 3-fenil-5,6-dihidrobenzo(c)-acridin-7-carboxilicos y compuestos relacionados como agentes quimioterapeuticos para el cancer.
NO873125L (no) Fremgangsmaate for fremstilling av antibakterielle forbindelser.
DK1465625T3 (da) Opløste topoisomerase-gifte
EE200000472A (et) Kasvajavastased toimeained
KR0148213B1 (en) Phenyla lkan(en)oic acid and pharmaceutical composition comprising the same
ATE170852T1 (de) Benzolsulfonamid-derivate zur behandlung der blaseninstabilität
BR9502079A (pt) Composto,formulação farmaceutica e processo para preparar um composto
FI891155A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 4,5,6,7-tetrahydroisotiatsolo/4,5-c/pyridiini-johdannaisten ja niiden isomeerien ja happoadditiosuolojen valmistamiseksi
DE69627519D1 (de) Sesquiterpen-derivate mit antiviraler aktivität
ATE234320T1 (de) Beta,beta-disubstituierte derivate von 9-deoxo-9a-n-ethenyl-9a-aza-9a-homoerythromycin a
FR2781482B1 (fr) Nouveaux derives de 8h-thieno-[2,3-b]pyrrolizine-8-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE69011174D1 (de) Catecholaminester.
DE69908855D1 (de) 9a, 11b-dehydro Derivative von 9-oxime-3-keto-6-0-methylerythromycin
EP0450232A3 (en) P-guanidino benzoic acid derivatives for treatment of cerebrovascular contraction
RU93058275A (ru) Производные тиофен-2-карбоновой кислоты, способ их получения, фармацевтическая композиция и способ ее получения

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 380038

Country of ref document: ES